Enhancement of circulatory antioxidants by α-ketoglutarate during sodium valproate treatment in Wistar rats

Polish Journal of Pharmacology

Volumn 55, Issue 1, 2003, Pages 31-36

  Murugesan, Vidya ^a   Subramanian, Perumal ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

ketoglutarate; Antioxidants; Hyperammonemia; Lipid peroxidation; Sodium valproate

Indexed keywords

2 OXOGLUTARIC ACID; ALPHA TOCOPHEROL; AMINOTRANSFERASE; AMMONIA; ANTIOXIDANT; ASCORBIC ACID; CATALASE; HYDROPEROXIDE DERIVATIVE; OXYGEN RADICAL; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA; VALPROIC ACID;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DECARBOXYLATION; DECOMPOSITION; HYPERAMMONEMIA; LIPID METABOLISM; LIPID PEROXIDATION; LIVER TOXICITY; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; KETOGLUTARIC ACIDS; LIPID PEROXIDATION; RATS; RATS, WISTAR; VALPROIC ACID;

EID: 0037249980     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Atalay A., Ogus A., Bateman O., Slingsby C.: Vitamin C induced oxidation of eye lens gamma crystalins. Biochimie, 1998, 80, 283-288.
2. Baker H., Frankel O., De Angelis B., Feingold S.: Plasma tocopherol in man at various times after ingesting free (or) acetylated tocopherol. Nutr. Rep. Int., 1980, 21, 531-536.
3. Bellei M., Battelli P., Guarrier D.M.: Changes in mitochondrial activity caused by ammonium salts and the protective effect of carnitine. Biochem. Biophys. Res. Commun., 1989, 158, 181-188.
4. Castro-Gago M.: Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital. J. Child Neurol., 1998, 13, 546-549.
5. Charles A., Williams M.D., Tiefenbach S., Mc Reynolds J.W.: Valproic acid-induced hyperammonemia in mentally retarded adults. Neurology, 1984, 34, 550-553.
6. Coodley E.L.: Enzyme diagnosis in hepatic disease. Amer. J. Gastroenterol., 1971, 56, 413-419.
7. Copper A.J.L., Kristal B.S.: Multiple roles of glutathione in the central nervous system. Biol. Chem., 1997, 378, 798-802.
8. da Fonseca-Wollheim F.: Preanalytical increase of ammonia in blood specimens from healthy subjects. Clin. Chem., 1990, 36, 1483-1487.
9. Farkas V., Bock I., Cseko J., Sandor A.: Inhibition of carnitine biosynthesis by valproic acid in rats: the biochemical mechanism of inhibition. Biochem. Pharmacol., 1996, 52, 1429-1433.
10. Fisher E., Siemens H., Pund R., Wittfoht W., Nau H.: Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity. Epilepsia, 1992, 33, 165-171.
11. Friedman M.I., Tordoff M.G.: Fatty acid oxidation and glucose utilization interact to control food intake in rats. Amer. J. Physiol., 1986, 251, R840-R845.
12. Gidal B.E.: Diet and valproate-induced transient hyperammonemia: effect of L-carnitine. Pediat. Neurol., 1997, 16, 301-305.
13. Jiang Z.Y., Hunt J.V., Wolff S.P.: Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal. Biochem., 1992, 202, 384-387.
14. Johannessen C.U.: Mechanisms of action of valproate: a commentary. Neurochem. Int., 2000, 37, 103-110.
15. Jorge J.A.: Some common issues in the use of antiepileptic drugs. Semin. Neurol., 2002, 22, 27-40.
16. Jurima-Romet M., Abbott F.S., Tang W., Huang H.S., Whitehouse L.W.: Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes. Toxicology, 1996, 112, 69-85.
17. Kakkar P., Das B., Viswanathan P.N.: A modified spectrophotometric assay of superoxide dismutase. Ind. J. Biochem., Biophys., 1984, 21, 130-132.
18. Kjellman V., Bjork K., Ekroth R.: Addition of alphaketoglutarate to blood cardioplegia improves cardio-protection. Ann. Thorac. Surg., 1997, 63, 1625-1634.
19. Koch K.M., Wilensky A.J., Levy R.H.: Beta-oxidation of valproic acid. I. Effects of fasting and glucose in humans. Epilepsia, 1989, 30, 782-789.
20. Konig St.A., Siemes H., Blaker F.: Severe hepatotoxicity during VPA therapy: an update and review of eight new fatalities. Epilepsia, 1994, 35, 1005-1015.
21. Kosenko E., Kaminsky Y., Stavroskaya I.G., Felipo V.: Alteration of mitochondrial calcium homeostasis by ammonia-induced activation of NMDA receptors in rat brain in vivo. Brain Res., 2000, 880, 139-146.
22. Lasch P., Petras T., Ullrich O., Backmann J., Naumann D., Grune T.: Hydrogen peroxide-induced structural alterations of RNAseA. J. Biol. Chem., 2001, 276, 9492-9502.
23. Lehninger A.L., Nelson D.L., Cox M.M.: Principles of Biochemistry. 3rd edn., CBS Publishers, New Delhi, 2000.
24. National Institutes of Health: Guide for the Care and Use of Laboratory Animals, DHEW Publication (NIH), revised (1985), Office of Science and Health Reports, DRR/NIH, Bethesda, USA.
25. Nelson N.L., Cox M.M.: Lehninger Principles of Biochemistry. Macmillan Worth Publishers, Hampshire, UK, 2000.
26. Nichans W.G., Samuelson B.J.: Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem., 1968, 6, 126-130.
27. Nikiforov A.A.: Stimulation by amino oxyacetate of fluorescein uptake in rat renal tubules in vitro: role of intracellular α-ketoglutarate. J. Pharmacol. Exp. Ther., 1995, 274, 1204-1208.
28. Niknahad H., O'Brien P.J., Khan S., Soop C.: Prevention of cyanide-induced cytotoxicity by nutrients in isolated rat hepatocytes. Toxicol. Appl. Pharnacol., 1994, 128, 271-279.
29. Raul F., Gosse F., Galluser M., Hasselmann M., Seiler N.: Functional and metabolic changes in intestinal mucosa of rats after enteral administration of ornithine α-ketoglutarate salt. J. Parent. Enter. Nutr., 1995, 19, 145-150.
30. Reitman S., Frankel A.S.: A colorimetric method for the determination of serum glutamic, oxaloacetic and glutamic pyruvic transaminases. Amer. J. Clin. Pathol., 1995, 28, 56.
31. Roe J.H., Kuether C.A.: Detection of ascorbic acid in whole blood and urine through the 2,4 - DNPH derivative of dehydroascorbic acid. J. Biol. Chem., 1946, 11, 145-164.
32. Roe D.S., Roe C.R., Brivet M., Sweetman L.: Evidence for a short-chain carnitine-acylcarnitine translocase in mitochondria specifically related to the metabolism of branched-chain amino acids. Mol. Genet. Metab., 2000, 69, 69-75.
33. Siddique M.A.A., Nazmi A.S., Razia K., Karim S., Pal S.N., Pillai K.K.: Oxidative damage in mice liver induced by sodium valproate: protection by melatonin. Ind. J. Pharmacol., 1999, 31, 427-430.
34. Sinha K.A.: Colorimetric assay of catalase. Anal. Biochem., 1972, 47, 3889-3894.
35. Stephens J.R., Levy R.H.: Effects of valproate and citrulline on ammonium-induced encephalopathy. Epilepsia, 1994, 35, 164-171.
36. Szupera Z., Mezei Z., Kis B., Gecse A., Vecsei L., Telegdy G.: The effects of valproate on the arachidonic acid metabolism of rat brain microvessels and of platelets. Eur. J. Pharmacol., 2000, 387, 205-210.
37. Tabatabaci A.R., Abbott F.S.: Assessing the mechanism of metabolism-dependent valproic acid-induced in vitro cytotoxicity. Chem. Res. Toxicol., 1999, 12, 323-330.
38. Varley H., Gowenlock A. H., Bell M.: Diacetyl monoxime method. In: Practical Clinical Biochemistry, 5th edn., CBS Publishers 1, 1991, 459-460.
39. Vaubourdolle M., Lucas C.C.: Action of enterally administered ornithine α-ketoglutarate on protein breakdown in skeletal muscle and liver of burned rat. J. Parent. Enter. Nutr., 1991, 155, 517-520.
40. Velvizhi S., Nagalashmi T., Essa M., Dakshayani K.B., Subramaian P.: Effects of α-ketoglutarate on lipid peroxidation and antioxidant status during chronic ethanol administration in Wistar rats. Pol. J. Pharmacol., 2002, 54, 231-236.
41. Wernerman J., Hammarqvist F., Vinnars F.: Alphaketoglutarate and post operative muscle catabolism. Lancet, 1990, 335, 701-703.